-The Hindu Stereotypical government policies and global approaches persist in family planning programmes. Urmila is a 40-year-old domestic worker in western Uttar Pradesh. The mother of six children, all girls, she is now pregnant again and is keen on carrying on with the pregnancy. Her husband is unemployed and is an alcoholic. His relatives have assured her that they will help her to bring up the child and have also hinted...
More »SEARCH RESULT
Total Matching Records found : 697
The Assam tangle -Samudra Gupta Kashyap
-The Indian Express A little over 11 years ago, when the Congress defeated the Asom Gana Parishad and Tarun Gogoi took over as chief minister of Assam, people had their doubts. Would this man who had spent most of his political career since 1971 as a Lok Sabha member be able to run this state? The state, with its unique tangle of ethnicity and politics, has, after all, always been a...
More »NAC forms panel for health plan roll-out -Vidya Krishnan & Anuja
-Live Mint The Sonia Gandhi led-National Advisory Council (NAC) on Friday formed a working group on universal health coverage for phasing-in the roll-out of the proposed scheme in the 12th Five-Year Plan period. Meanwhile, differences persist between the health ministry and the Planning Commission on the role of insurance and the private sector within the universal health coverage (UHC) plan. Health ministry and Planning Commission officials presented their views to the NAC on...
More »Govt on warpath with plan panel-Kounteya Sinha
-The Times of India The idea of a single National Health Mission to address the health challenges of the country's rural and urban population, as envisaged by the Planning Commission, is in the eye of a storm. The Union health ministry has made its stand clear that a uniform approach can never work. The letter written by the ministry to the Commission says that the health facilities in rural areas conform to a...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
